Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Biology Laboratory, |
RCV001281145 | SCV001425102 | pathogenic | Infantile nephronophthisis | 2020-02-01 | criteria provided, single submitter | research | |
Fulgent Genetics, |
RCV001281145 | SCV002808720 | pathogenic | Infantile nephronophthisis | 2024-02-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002570439 | SCV003510766 | pathogenic | Nephronophthisis | 2023-12-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp495*) in the INVS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in INVS are known to be pathogenic (PMID: 12872123). This variant is present in population databases (rs149055711, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with nephronophthisis (PMID: 33532864). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 974395). For these reasons, this variant has been classified as Pathogenic. |